Link between ADT and cardiovascular death not found
Added: Saturday 25 February 2012
A pooled analysis of medical research databases found no evidence that androgen deprivation therapy (ADT) increases cardiovascular mortality. In addition, the use of ADT in men with
unfavorable-risk prostate cancer was found to be associated with
improved prostate cancer–specific survival and overall survival. ADT is frequently used in treating prostate cancer, but there has been controversy about a possible link between ADT and cardiovascular deaths.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: